Evrys Bio
  • Home
  • Our Team
  • Platform & Pipeline
    • Platform and Pipeline
    • Curated Publications about Sirtuins
    • JCI Paper April 2023
  • News
    • Recent News
    • News Archive
  • Contact Us
    • Driving Directions and Map
    • Contact Us Form
  • Evrys Bio Slide Deck
  • Presentation Video
  • Jobs
  • Menu Menu

NIAID Antiviral Summit Report

Uncategorized
Hall 2021 NIAID SARS Antiviral Summit Report Published
August 2, 2021
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://evrysbio.com/wp-content/uploads/2019/05/EvrysLogo_web-300x138.png 0 0 Dana Merriman https://evrysbio.com/wp-content/uploads/2019/05/EvrysLogo_web-300x138.png Dana Merriman2021-08-02 14:31:522021-08-02 14:32:49NIAID Antiviral Summit Report

Recent Posts

  • SIRT2 MODULATION AND EBV INFECTION
  • Proprietary Sirtuin-2 Modulator reduces Hepatitis B Virus infectivity
  • NIAID Antiviral Summit Report
  • Evrys Bio Awarded $34 Million from DOD to Develop a Single Drug Simultaneously Effective Against Multiple Lethal Viruses
  • Evrys Bio Joins the Call to Arms

Archives

  • July 2022
  • November 2021
  • August 2021
  • July 2021
  • March 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • November 2019
  • July 2019
  • May 2019
  • April 2019
  • November 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • April 2018
  • February 2018
  • December 2017
  • November 2017
  • May 2017
  • February 2017
  • January 2017
  • October 2016
  • September 2016
  • August 2016
  • June 2016
  • October 2015
  • August 2015
  • February 2015
  • December 2014
  • October 2014
  • September 2014
  • August 2014
  • June 2014
  • February 2014
  • January 2014

Categories

  • News
  • Uncategorized

Sitemap

  • Contact Us
  • Contact Us Form
  • Curated Publications about Sirtuins
  • Driving Directions and Map
  • Evrys Bio Slide Deck
  • Home
  • JCI Paper April 2023
  • Jobs
  • Name Change
  • News
  • Our Team
    • Advisors and Board Members
    • Management and Scientists
    • Our Team 3
  • Our Team
  • Our Team 2
  • Platform and Pipeline
  • Presentation Video CEO & Investor 2021
  • Privacy Policy
  • Recent News

Evrys Bio

3805 Old Easton Road
Doylestown, PA 18902

Federal Conflict of Interest Policy Statement

View the FCOI POL_0006 FCOI_1_0
pertaining to federally funded projects

Best University Startups
© Copyright - Evrys Bio
Evrys Bio Awarded $34 Million from DOD to Develop a Single Drug Simultaneously...Proprietary Sirtuin-2 Modulator reduces Hepatitis B Virus infectivity
Scroll to top
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsRead MoreACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT